HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harum, K. H. Articles by Johnston, M. V. Search for Related Content PubMed PubMed Citation Articles by Harum, K. H. Articles by Johnston, M. V. Related Collections All Pediatric All Cognitive Disorders/Dementia All Genetics

Cognitive impairment in Coffin–Lowry syndrome correlates with reduced RSK2 activation

From the Kennedy Krieger Institute (Drs. Harum and Johnston and L. Alemi), Baltimore; and The Johns Hopkins University School of Medicine, Departments of Pediatrics (Drs. Harum and Johnston) and Neurology (Dr. Johnston), Baltimore, MD.

Address correspondence and reprint requests to Dr. Karen H. Harum, Kennedy Krieger Institute, 707 No. Broadway, Baltimore, MD 21205; e-mail: Harum{at}kennedykrieger.org

BACKGROUND: Gene expression and protein synthesis, mediated by the transcription factor CREB (cAMP response element binding protein), play an important role in learning and memory in several species, including Drosophila, snails, and mice. Patients with the X-linked disorder Coffin–Lowry syndrome (CLS) have cognitive disabilities, distinctive features, and bony abnormalities as well as mutations in RSK2 (ribosomal S6 kinase-2), a protein kinase that activates CREB by phosphorylation at serine 133. In fibroblasts from a single patient with CLS, epidermal growth factor (EGF)–stimulated CREB phosphorylation was reduced.

METHODS: The authors assessed endogenous CREB phosphorylation in a CLS fibroblast line by Western blotting and found impaired CREB phosphorylation in response to stimulation by EGF and the protein kinase C (PKC) agonist phorbol 12-myristate 13-acetate (PMA). They studied RSK2 immunoprecipitated from fibroblasts and lymphoblasts from seven patients with CLS and found a wide range in RSK2’s capacity to phosphorylate the synthetic CREB-like peptide, CREBtide, after cell stimulation by PMA.

RESULTS: In lymphoblasts from patients with CLS, PMA-stimulated CREBtide phosphorylation was increased 1.2- to 2.7-fold over baseline, compared to an average fourfold increase in controls. Regression analysis suggested a linear relationship between the magnitude of in vitro RSK2-mediated CREBtide phosphorylation and CLS patient intelligence level (p < 0.05).

CONCLUSIONS: This report suggests a correlation between human cognitive performance and cellular capacity to activate RSK2. It provides additional evidence that the CREB kinase, RSK2, and CREB phosphorylation may play important roles in human learning and memory, as they do in lower animals.

This article has been cited by other articles:

				Y.-Y. Cho, Z. He, Y. Zhang, H. S. Choi, F. Zhu, B. Y. Choi, B. S. Kang, W.-Y. Ma, A. M. Bode, and Z. Dong The p53 Protein Is a Novel Substrate of Ribosomal S6 Kinase 2 and a Critical Intermediary for Ribosomal S6 Kinase 2 and Histone H3 Interaction Cancer Res., May 1, 2005; 65(9): 3596 - 3603. [Abstract] [Full Text] [PDF]

				K. M. Eisenmann, M. W. VanBrocklin, N. A. Staffend, S. M. Kitchen, and H.-M. Koo Mitogen-Activated Protein Kinase Pathway-Dependent Tumor-Specific Survival Signaling in Melanoma Cells through Inactivation of the Proapoptotic Protein Bad Cancer Res., December 1, 2003; 63(23): 8330 - 8337. [Abstract] [Full Text] [PDF]

				B. Hendrich and W. Bickmore Human diseases with underlying defects in chromatin structure and modification Hum. Mol. Genet., October 1, 2001; 10(20): 2233 - 2242. [Abstract] [Full Text] [PDF]